Scutellaria Alpina Extract Whitening Composition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current skin whitening agents, such as kojic acid and hydroquinone, exhibit unsatisfactory skin whitening effects and cause skin irritation due to instability and low efficacy in reducing melanin production.

Innovation Solution

A composition containing a Scutellaria alpina extract is used to inhibit tyrosinase activity and reduce melanin production, providing a superior skin whitening effect while maintaining stability and minimizing cell damage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If kojic acid, hydroquinone, arbutin, azelaic acid, aloesin, 4-butylresorcinol, resveratrol, ceramide, sphingosine-1-phosphate, or sphingosylphosphorylcholine is used to control melanin production, then melanin production is regulated, but skin whitening effect is unsatisfactory and skin irritation occurs due to low stability

Engineering Contradiction:
Improvestability of whitening agentVSAvoidskin irritation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent uses Scutellaria alpina extract as an intermediary substance that indirectly regulates melanin production through multiple pathways (inhibiting tyrosinase activity, blocking melanin transfer, reducing oxidative stress) rather than directly attacking melanin synthesis, thereby achieving whitening效果 with reduced skin irritation and improved stability

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical parameters of the whitening agent by using a natural plant extract (Scutellaria alpina) with different molecular structure and composition compared to conventional agents like kojic acid or hydroquinone, resulting in improved stability and reduced harmful effects while maintaining whitening efficacy

Inventive Principle:
Principle #35Parameter changes

2Productivity

If conventional whitening agents are used to reduce melanin production, then some whitening effect is achieved, but the overall skin whitening effect is unsatisfactory

Engineering Contradiction:
Improveskin whitening effectVSAvoidstability of agent
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent employs a composite approach by using Scutellaria alpina extract which contains multiple active compounds (flavonoids, phenolic acids, alkaloids) working synergistically to inhibit melanin production through multiple mechanisms, thereby achieving superior and more stable whitening效果 compared to single-agent conventional treatments

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Scutellaria alpina extract effectively decreases melanin content and tyrosinase activity, offering a stable and effective skin whitening solution for various skin pigmentation disorders with minimal side effects.

Implementation Method 1

inhibiting its activity

Methodology Applied
Scientific EffectEnzyme inhibition: Enzyme

Data Source

PatentEP3162375B1Whitening composition comprising scutellaria alpina extract
Publication Date: 2019.11.06 AMOREPACIFIC CORP
  • EP3162375B1 patent drawingFigure 1
  • EP3162375B1 patent drawingFigure 2
  • EP3162375B1 patent drawing

AI summary

The present specification discloses a composition comprising a Scutellaria alpina extract as an active ingredient. The composition disclosed in the present specification exhibits the effect of reducing melanogenesis or inhibiting tyrosinase activity by comprising the Scutellaria alpina extract. As a result of the effect, the Scutellaria alpina extract of the present specification can exhibit a whitening effect and thus can be widely used as a whitening composition in the field of pharmaceuticals or cosmetics.